Abstract
e15600Background: In spite of successful approval and wide application of sorafenib, the prognosis for patients with advanced hepatocellular carcinoma (HCC) remains poor. In recent years, highly tu...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have